Checkpoint Therapeutics shares pop on acquisition by Sun Pharma
Portfolio Pulse from
Checkpoint Therapeutics shares surged over 60% following the announcement of its acquisition by Sun Pharmaceutical Industries for $4.10 per share, totaling up to $355 million in upfront payments.
March 10, 2025 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Checkpoint Therapeutics shares jumped over 60% after Sun Pharma announced its acquisition for $4.10 per share, totaling $355 million in upfront payments.
The acquisition by Sun Pharma at a premium price of $4.10 per share led to a significant increase in CKPT's stock price, reflecting investor optimism and the premium valuation.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100